Aurobindo Splits Out Biosimilars Business

Firm Upbeat On Outlook As It Seeks FDA Desk Reviews For Three Units

 
• By Vibha Ravi
  
Business growth
Aurobindo Looks For Growth As It Carves Out Biologics Business • Source: Shutterstock

More from Strategy

More from Business